We need your help to achieve the goal of growing our online, geographically searchable database of resources and support for cancer patients, their families and caregivers. Whether you're in the initial phase of shock, in the battle, or handling the aftermath of cancer, our resources take out the stress of searching multiple places and thousands of online listings.
When health conditions cause a buildup of lymph fluid, people can use lymphatic drainage massage to get this fluid moving. In this article, we discuss the benefits of lymphatic massage and how to do it at home.
R-CHOP chemotherapy uses a combination of five different drugs to treat specific types of cancer, including non-Hodgkin lymphoma. Learn more about how this treatment works and the potential side effects here.
The symptoms, treatment, and survival rates of stage 4 lymphoma depend on the type of lymphoma and the risk factors that the individual has. Learn more here.
Hepatitis C is a viral infection with different treatment options. Medication, treatments, and care pricing depend on factors that include a person’s insurance policy and their overall health. There are various medications available. Learn more about the costs of hepatitis C treatment here.
Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. Although doctors can very rarely cure CLL, survival rates for this cancer are typically good. A person’s life expectancy for CLL depends on how far the cancer has progressed and when they receive treatment. Learn more here.
When the cells in the blood do not function as they should, it is possible a person has a blood disorder. Examples include leukemia, lymphoma, and myeloma. Common blood disorder symptoms include unexplained exhaustion and weight loss. Learn more about the types of blood disorder and the signs to look out for here.
Cancer thrives on the buildup of 'nutrients' that can damage healthy cells. But can cancer cells have 'too much of a good thing?' Researchers investigate.
With more targeted therapies being approved each year for cancer, the development of drug resistance to these agents is a growing concern.
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small molecule drug discovered at the institution may help overcome resistance to treatment with ibrutinib in patients with mantle cell lymphoma.
New findings about a fatal form of blood cancer could aid the development of new drugs with significantly less harmful side effects than existing chemotherapy.
Many individuals forced to fight an exceptionally aggressive form of the blood cancer acute myeloid leukemia (AML) don't survive more than five years.
11,000 people are predicted to die from acute myeloid leukemia in 2019, according to the American Cancer Society. The cancer starts in the bone marrow. There, mutated genes fail to prevent blood cells from replicating again and again and again, growing tumors.
Acute erythroid leukemia is a high-risk cancer with a dismal prognosis, uncertain genetic basis and controversy surrounding the diagnosis. That is changing, thanks to research led by St. Jude Children's Research Hospital that appears today in the journal Nature Genetics.
The prognosis for older patients with acute myeloid leukemia is poor: very few achieve remission and for those that don't the option is largely palliative.